Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death

Stroke

Volumn 37, Issue 1, 2006, Pages 129-133

  Saloheimo, Pertti ^a,c   Ahonen, Mikko ^a   Juvela, Seppo ^b   Pyhtinen, Juhani ^a   Savolainen, Eeva Riitta ^a   Hillbom, Matti ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

Aspirin; Cerebral hemorrhage; Mortality; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CONSCIOUSNESS DISORDER; DEATH; DRUG USE; FEMALE; FINLAND; HEMATOMA ENLARGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; BLEEDING; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; HEMATOMA; IATROGENIC DISEASE; MIDDLE AGED; PATHOLOGY; RISK; STATISTICAL MODEL; THROMBOCYTE TRANSFUSION; TIME; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; HEMATOMA; HEMORRHAGE; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLATELET AGGREGATION INHIBITORS; PLATELET TRANSFUSION; RISK; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 33644877060     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000196991.03618.31     Document Type: Article

References (22)

1. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:349-353.
2. Franke CL, van Swieten JC, Algra A, van Gijn J. Prognostic factors in patients with intracerebral hematoma. J Neurol Neurosurg Psychiatry. 1992;55:653-657.
3. Juvela S. Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol. 1995;52:1193-1200.
4. Inagawa T, Shibukawa M, Inokuchi F, Tokuda Y, Okada Y, Okada K. Primary intracerebral and aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Part II: Management and surgical outcome. J Neurosurg. 2000;93:967-975.
5. Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Hier DB, Kase CS. Intracerebral haemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991;29:658-663.
6. Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome. A systematic review. Hypertension. 2004;43:18-24.
7. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracerebral haemorrhage. Facts and hypotheses. Stroke. 1995;26:1471-1477.
8. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral haemorrhage. Arch Intern Med. 2004;164:880-884.
9. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, haematoma expansion, and outcome of intracerebral haemorrhage. Neurology. 2004;63:1059-1064.
10. Nilsson OG, Lindgren A, Brandt L, Säveland H. Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg. 2002;97:531-536.
11. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH Score. A simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891-897.
12. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2:81-94.
13. Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;1:480-484.
14. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
15. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
16. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29:1160-1166.
17. The Swedish Aspirin Low-dose Trial Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.
18. Saloheimo P, Juvela S, Riutta A, Pyhtinen J, Hillbom M. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thromb Res. 2005;115:367-373.
19. Takahashi H, Urano T, Nagai N, Takada Y, Takada A. Progressive expansion of hypertensive intracerebral haemorrhage by coagulopathy. Am J Haematol. 1998;59:110-114.
20. Fang H-Y, Lin C-Y, Ko W-J. Haematology and coagulation parameters predict outcome in Taiwanese patients with spontaneous intracerebral haemorrhage. Eur J Neurol. 2005;12:226-232.
21. Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Vcohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke. 1999;30:2025-2032.
22. Olson JD. Hemostasis and hematologic conditions in intracerebral hemorrhage. In Kaufman HH, ed. Intracerebral hematomas. New York, NY: Raven Press, 1993:151-162.